Skip to main content
News Icon

PhD Students Organize UN Visit

Our PhD Students representative Amir Hossein Kayvanjoo organized a visit to the UN on February 14th.

The visit was focused on the career and internship opportunities in the UN organization! It was great to see many PhD students were interested and more than 20 participants took part.

During the tour we were presented with the career options that one can have and also different tracks to enter into the UN. In addition we were also given a brief introduction into the structure of the UN. The visit ended with a walk in the last floor of the UN Campus tower. This was the highlight of our tour as everyone enjoyed not only the view of Bonn from the second tallest building in the city but also the participants were able to see through Cologne and the Cologne cathedral!

Hopefully more events organized by the great PhD representatives are to come.

Related news

Pandyra Publication Graphical Abstract

News categories: Publication

Genetic mutation affects survival after viral infection

Scientists discovered that haploinsufficiency in the Pax5 gene affects antiviral responses. The study was led by Prof. Dr. Aleksandra Pandyra from the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn in collaboration with Prof. Dr. Arndt Borkhardt, Clinic Director at the Pediatric Oncology at the University Hospital Düsseldorf. The findings were published in the latest edition of EMBO Molecular Medicine.
View entry
Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry
AG Kürthen Multiple Sclerosis Bonn

News categories: Publication

Potential target for MS therapy discovered

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, which are a type of white blood cell, play a role in the development of MS and are thus a target for therapies. Researchers at the University Hospital Bonn (UKB), the University of Bonn and the FAU Erlangen-Nuremberg identified the membrane protein MLC1 as a potential target antigen in MS. The results of the work have now been published in the renowned journal “Neurology Neuroimmunology & Neuroinflammation”.
View entry

Back to the news overview